Featured Research

from universities, journals, and other organizations

NCI Begins Validation Study Of New Test To Detect Early–Stage Liver Cancer

Date:
March 3, 2005
Source:
NIH/National Cancer Institute
Summary:
A two-year study to validate a test to detect early-stage liver cancer has been initiated by the National Cancer Institute (NCI), part of the National Institutes of Health, at six centers across the United States. This test, conceived with the assistance of NCI’s Early Detection Research Network (EDRN), looks at whether a substance called des-gamma carboxyprothrombin (DCP) can identify those at risk for liver cancer.

A two-year study to validate a test to detect early-stage liver cancer has been initiated by the National Cancer Institute (NCI), part of the National Institutes of Health, at six centers across the United States. This test, conceived with the assistance of NCI’s Early Detection Research Network (EDRN), looks at whether a substance called des-gamma carboxyprothrombin (DCP) can identify those at risk for liver cancer.

Validation — proving that the measurement of a substance accurately signifies the risk for or presence of cancer —is the critical step to create a truly useful test. “It’s the first study testing a marker for liver cancer, and the first Phase II EDRN-supported study,” said Sudhir Srivastava, Ph.D., who heads EDRN as chief of the Cancer Biomarkers Research Group in NCI’s Division of Cancer Prevention.

Liver cancer, or hepatocellular carcinoma, with over 20,000 estimated new cases this year in the United States, is both one of the more common cancers worldwide and one of the few cancers in the United States in which the number of new cases is rising, and expected to continue to rise over the next two decades. Frequent surveillance of patients with liver cirrhosis is recommended, but current procedures have shortcomings. Alpha-fetoprotein, a blood test currently used for surveillance of liver cancer, suffers from poor sensitivity and specificity (ability to determine if someone actually has, or does not have, liver cancer). Liver ultrasound is dependent on the skills and knowledge of the technician and can lead to false-negative results. This EDRN-supported study looks to improve upon these negatives.

DCP is a protein precursor of prothrombin, one of the factors produced by the liver to help the blood clot. In patients with liver cancer, this protein seems to be elevated compared to those without liver cancer. Early studies have shown that DCP is better than alpha-fetoprotein for the diagnosis of liver cancer and has close to 90 percent accuracy.

The investigators conducting the validation study, headed by Jorge A. Marrero, M.D., of the University of Michigan, and Paul Wagner, Ph.D., program director in NCI’s Cancer Biomarkers Research Group, plan to enroll 450 patients diagnosed with liver cancer, of which at least 170 will be early stage. Four hundred fifty patients with cirrhosis and no cancer will serve as controls. The participating institutions will collect samples from patients in this study, and the samples will be analyzed for DCP using an assay manufactured by Eisai Company, Teaneck, N.J. The primary goal of the study is to determine whether DCP can lead to improved accuracy in the detection of early-stage hepatocellular carcinoma.

This trial will run for two years and final results are expected in early 2007. If successful, this study will provide a much-needed tool for the early detection of liver cancer. Additionally, EDRN’s gastrointestinal collaborative group is working on two other early novel detection tests for liver cancer for future validation.

EDRN, established by NCI in early 2000, is a broad, interdisciplinary consortium whose work is aimed at both identifying and validating cancer biomarkers for use in early cancer detection, and is divided among collaborative groups studying specific tumors. Numerous proteins and genes have been linked with a variety of cancers, which can make them targets for therapy, as well as targets for identifying the risk of cancer onset, progression, or recurrence.

For more information about the Early Detection Research Network (EDRN), visit the EDRN home page at <http://www3.cancer.gov/prevention/cbrg/edrn>

For more information about cancer, visit the NCI Web site at <http://www.cancer.gov> or call NCI's Cancer Information Service at 1-800-4-CANCER (1-800-422-6237).


Story Source:

The above story is based on materials provided by NIH/National Cancer Institute. Note: Materials may be edited for content and length.


Cite This Page:

NIH/National Cancer Institute. "NCI Begins Validation Study Of New Test To Detect Early–Stage Liver Cancer." ScienceDaily. ScienceDaily, 3 March 2005. <www.sciencedaily.com/releases/2005/02/050225105643.htm>.
NIH/National Cancer Institute. (2005, March 3). NCI Begins Validation Study Of New Test To Detect Early–Stage Liver Cancer. ScienceDaily. Retrieved September 30, 2014 from www.sciencedaily.com/releases/2005/02/050225105643.htm
NIH/National Cancer Institute. "NCI Begins Validation Study Of New Test To Detect Early–Stage Liver Cancer." ScienceDaily. www.sciencedaily.com/releases/2005/02/050225105643.htm (accessed September 30, 2014).

Share This



More Health & Medicine News

Tuesday, September 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

How 'Yes Means Yes' Defines Sexual Assault

How 'Yes Means Yes' Defines Sexual Assault

Newsy (Sep. 29, 2014) Aimed at reducing sexual assaults on college campuses, California has adopted a new law changing the standard of consent for sexual activity. Video provided by Newsy
Powered by NewsLook.com
Scientists May Have Found An Early Sign Of Pancreatic Cancer

Scientists May Have Found An Early Sign Of Pancreatic Cancer

Newsy (Sep. 29, 2014) Researchers looked at 1,500 blood samples and determined people who developed pancreatic cancer had more branched chain amino acids. Video provided by Newsy
Powered by NewsLook.com
Colo. Doctors See Cluster of Enterovirus Cases

Colo. Doctors See Cluster of Enterovirus Cases

AP (Sep. 29, 2014) Doctors at the Children's Hospital of Colorado say they have treated over 4,000 children with serious respiratory illnesses since August. Nine of the patients have shown distinct neurological symptoms, including limb weakness. (Sept. 29) Video provided by AP
Powered by NewsLook.com
Dr.'s Unsure of Cause of Fast-Spreading Virus

Dr.'s Unsure of Cause of Fast-Spreading Virus

AP (Sep. 29, 2014) Doctors at the Children's Hospital of Colorado say they have treated over 4,000 children with serious respiratory illnesses since August. Nine of the patients have shown distinct neurological symptoms, including limb weakness. (Sept. 29) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins